278 related articles for article (PubMed ID: 10677157)
21. Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass.
Nicholson SC; Keeling DM; Sinclair ME; Evans RD
Br J Anaesth; 2001 Dec; 87(6):844-7. PubMed ID: 11878684
[TBL] [Abstract][Full Text] [Related]
22. Adjusted calculation model of heparin management during cardiopulmonary bypass in obese patients: A randomised controlled trial.
Vienne M; Haas E; Wipf T; Grunebaum L; Levy F; Sattler L; Hoang Minh T; Severac F; Tacquard C; Collange O; Mertes PM; Steib A
Eur J Anaesthesiol; 2018 Aug; 35(8):613-620. PubMed ID: 29521662
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
[TBL] [Abstract][Full Text] [Related]
24. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.
Wang JS; Lin CY; Karp RB
Anesth Analg; 1994 Jul; 79(1):9-13. PubMed ID: 8010461
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
Wallock M; Jeske WP; Bakhos M; Walenga JM
Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
[TBL] [Abstract][Full Text] [Related]
26. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
Muedra V; Bonanad S; Gómez M; Villalonga V; Sánchez F; Llopis JE
Perfusion; 2011 Nov; 26(6):487-95. PubMed ID: 21665912
[TBL] [Abstract][Full Text] [Related]
27. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
[TBL] [Abstract][Full Text] [Related]
28. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?
Boldt J; Knothe C; Welters I; Dapper FL; Hempelmann G
Ann Thorac Surg; 1996 Jul; 62(1):130-5. PubMed ID: 8678631
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
30. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
[TBL] [Abstract][Full Text] [Related]
31. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.
Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH
Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937
[TBL] [Abstract][Full Text] [Related]
32. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
[TBL] [Abstract][Full Text] [Related]
34. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
35. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
36. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
[TBL] [Abstract][Full Text] [Related]
37. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
[TBL] [Abstract][Full Text] [Related]
38. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.
Hashimoto K; Yamagishi M; Sasaki T; Nakano M; Kurosawa H
Ann Thorac Surg; 1994 Sep; 58(3):799-804; discussion 804-5. PubMed ID: 7944706
[TBL] [Abstract][Full Text] [Related]
39. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
[TBL] [Abstract][Full Text] [Related]
40. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
